<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Network Disconnection and Synaptic Failure Theory of Alzheimer's Disease Detection - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-548</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-548</p>
                <p><strong>Name:</strong> Network Disconnection and Synaptic Failure Theory of Alzheimer's Disease Detection</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of the cause of Alzheimer's disease and how it can be effectively detected, based on the following results.</p>
                <p><strong>Description:</strong> This theory posits that the earliest and most functionally relevant events in Alzheimer's disease (AD) are disruptions of large-scale brain network connectivity and synaptic integrity, which can be detected by advanced neuroimaging and fluid biomarkers before substantial structural atrophy or overt clinical symptoms. The theory asserts that Aβ and tau pathologies, as well as metabolic, inflammatory, and vascular changes, converge on the synapse and network level, leading to impaired functional connectivity (especially in the default mode and memory networks) and synaptic loss, which are the proximate causes of cognitive decline. Therefore, the most sensitive and specific detection of AD, especially in preclinical and prodromal stages, is achieved by combining functional connectivity (fMRI, EEG/MEG), synaptic density (SV2A PET, neurogranin), and network-level biomarkers, rather than relying solely on Aβ/tau or structural atrophy.</p>
                <p><strong>Knowledge Cutoff Year:</strong> 2024</p>
                <p><strong>Knowledge Cutoff Month:</strong> 6</p>
            </div>
        </div>

        <div class="section">
            <h2>Theory (Derived From)</h2>
            <p><strong>Derived From:</strong> <span class="empty-note">None</span></p>
            <p><strong>Change Log:</strong> <span class="empty-note">No change log entries.</span></p>
        </div>

        <div class="section">
            <h2>Evaluations of this Theory</h2>
            <p class="empty-note">No evaluations of this theory.</p>
        </div>

        <div class="section">
            <h2>Theory (Details)</h2>

            <h3>Theory Statements</h3>
            <h3>Statement 0: Early Network Disconnection Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; individual &#8594; is_in &#8594; preclinical or prodromal AD stage</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; functional connectivity &#8594; is_reduced &#8594; in default mode and memory networks (DMN, hippocampal circuits)<span style="color: #888888;">, and</span></div>
        <div>&#8226; synaptic density &#8594; is_reduced &#8594; regionally (e.g., SV2A PET, neurogranin)</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Resting-state fMRI, functional connectivity, and SV2A PET studies show early network and synaptic changes in AD and MCI, often before atrophy. <a href="../results/extraction-result-3910.html#e3910.1" class="evidence-link">[e3910.1]</a> <a href="../results/extraction-result-3923.html#e3923.8" class="evidence-link">[e3923.8]</a> <a href="../results/extraction-result-3936.html#e3936.3" class="evidence-link">[e3936.3]</a> <a href="../results/extraction-result-4031.html#e4031.5" class="evidence-link">[e4031.5]</a> <a href="../results/extraction-result-3902.html#e3902.0" class="evidence-link">[e3902.0]</a> <a href="../results/extraction-result-3940.html#e3940.13" class="evidence-link">[e3940.13]</a> <a href="../results/extraction-result-3936.html#e3936.8" class="evidence-link">[e3936.8]</a> <a href="../results/extraction-result-3910.html#e3910.7" class="evidence-link">[e3910.7]</a> <a href="../results/extraction-result-4025.html#e4025.0" class="evidence-link">[e4025.0]</a> </li>
    <li>Functional connectivity impairment (disconnection hypothesis) is observed in early AD and MCI, with high classification accuracy using rs-fMRI network features. <a href="../results/extraction-result-3902.html#e3902.0" class="evidence-link">[e3902.0]</a> <a href="../results/extraction-result-3910.html#e3910.1" class="evidence-link">[e3910.1]</a> <a href="../results/extraction-result-3923.html#e3923.8" class="evidence-link">[e3923.8]</a> <a href="../results/extraction-result-4025.html#e4025.0" class="evidence-link">[e4025.0]</a> </li>
    <li>Synaptic loss is observed early in AD and is the strongest pathological correlate of cognitive decline. <a href="../results/extraction-result-4031.html#e4031.5" class="evidence-link">[e4031.5]</a> <a href="../results/extraction-result-3936.html#e3936.3" class="evidence-link">[e3936.3]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p class="empty-note">No existing law comparison provided.</p>
            <h3>Statement 1: Synaptic Failure as Final Common Pathway Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; Aβ and tau pathology &#8594; is_present &#8594; in brain</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; synaptic function &#8594; is_disrupted &#8594; leading to network disconnection and cognitive decline</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Synaptic loss is the strongest pathological correlate of cognitive decline; Aβ and tau are shown to disrupt synaptic function and connectivity. <a href="../results/extraction-result-4031.html#e4031.5" class="evidence-link">[e4031.5]</a> <a href="../results/extraction-result-3933.html#e3933.4" class="evidence-link">[e3933.4]</a> <a href="../results/extraction-result-3933.html#e3933.1" class="evidence-link">[e3933.1]</a> <a href="../results/extraction-result-3910.html#e3910.1" class="evidence-link">[e3910.1]</a> <a href="../results/extraction-result-3933.html#e3933.2" class="evidence-link">[e3933.2]</a> <a href="../results/extraction-result-3933.html#e3933.3" class="evidence-link">[e3933.3]</a> <a href="../results/extraction-result-3933.html#e3933.10" class="evidence-link">[e3933.10]</a> <a href="../results/extraction-result-3933.html#e3933.8" class="evidence-link">[e3933.8]</a> </li>
    <li>Aβ oligomers and tau pathology disrupt synaptic plasticity and network connectivity, leading to cognitive impairment. <a href="../results/extraction-result-3933.html#e3933.4" class="evidence-link">[e3933.4]</a> <a href="../results/extraction-result-3933.html#e3933.1" class="evidence-link">[e3933.1]</a> <a href="../results/extraction-result-3933.html#e3933.2" class="evidence-link">[e3933.2]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p class="empty-note">No existing law comparison provided.</p>
            <h3>Statement 2: Functional Biomarker Superiority Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; detection_method &#8594; includes &#8594; functional connectivity or synaptic density measures</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; early detection accuracy &#8594; is_greater_than &#8594; detection using structural atrophy or Aβ/tau alone</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Functional imaging and synaptic markers (fMRI, SV2A PET, neurogranin) are sensitive to early changes and can predict conversion from MCI to AD. <a href="../results/extraction-result-3910.html#e3910.1" class="evidence-link">[e3910.1]</a> <a href="../results/extraction-result-3936.html#e3936.3" class="evidence-link">[e3936.3]</a> <a href="../results/extraction-result-4031.html#e4031.5" class="evidence-link">[e4031.5]</a> <a href="../results/extraction-result-3923.html#e3923.8" class="evidence-link">[e3923.8]</a> <a href="../results/extraction-result-3902.html#e3902.0" class="evidence-link">[e3902.0]</a> <a href="../results/extraction-result-4025.html#e4025.0" class="evidence-link">[e4025.0]</a> <a href="../results/extraction-result-3936.html#e3936.8" class="evidence-link">[e3936.8]</a> </li>
    <li>Deep learning and graph-based models using functional connectivity outperform or complement structural MRI in early-stage classification. <a href="../results/extraction-result-3910.html#e3910.7" class="evidence-link">[e3910.7]</a> <a href="../results/extraction-result-4025.html#e4025.0" class="evidence-link">[e4025.0]</a> <a href="../results/extraction-result-3910.html#e3910.8" class="evidence-link">[e3910.8]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p class="empty-note">No existing law comparison provided.</p>
            <h3>Statement 3: Network Disconnection Precedes Structural Atrophy Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; individual &#8594; is_in &#8594; preclinical or prodromal AD stage</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; network connectivity &#8594; is_reduced &#8594; before measurable hippocampal or cortical atrophy</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>fMRI studies show DMN and hippocampal connectivity loss precedes gray matter loss; functional changes are detectable before atrophy. <a href="../results/extraction-result-3940.html#e3940.13" class="evidence-link">[e3940.13]</a> <a href="../results/extraction-result-3910.html#e3910.1" class="evidence-link">[e3910.1]</a> <a href="../results/extraction-result-3923.html#e3923.8" class="evidence-link">[e3923.8]</a> <a href="../results/extraction-result-3936.html#e3936.8" class="evidence-link">[e3936.8]</a> <a href="../results/extraction-result-4025.html#e4025.0" class="evidence-link">[e4025.0]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p class="empty-note">No existing law comparison provided.</p>
            <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Longitudinal studies will show that reductions in DMN connectivity and synaptic density (by fMRI/SV2A PET/neurogranin) precede measurable hippocampal atrophy or clinical symptoms in at-risk individuals.</li>
                <li>Combining functional connectivity and synaptic biomarkers with Aβ/tau markers will improve prediction of cognitive decline and conversion from MCI to AD.</li>
                <li>Individuals with preserved network connectivity and synaptic density, despite Aβ/tau positivity, will have slower or absent cognitive decline.</li>
                <li>Early interventions that restore or preserve network connectivity will delay onset of clinical symptoms even in biomarker-positive individuals.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Interventions that restore or preserve network connectivity and synaptic function (e.g., synaptoprotective drugs, neuromodulation) will prevent or delay cognitive decline even in the presence of Aβ/tau pathology.</li>
                <li>Distinct patterns of network disconnection (e.g., DMN vs. attention networks) will predict different clinical phenotypes or rates of progression in AD.</li>
                <li>Non-invasive EEG/MEG network biomarkers will be as sensitive as fMRI or PET for early AD detection.</li>
                <li>Network-level biomarkers will allow subtyping of AD with different progression rates or responses to therapy.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>If individuals with early Aβ/tau pathology but preserved network connectivity and synaptic density develop cognitive decline at the same rate as those with network disruption, the theory would be challenged.</li>
                <li>If functional connectivity and synaptic biomarkers do not improve early detection or prediction of progression compared to structural or Aβ/tau markers alone, the theory's central claim would be undermined.</li>
                <li>If network disconnection is not observed in preclinical or prodromal stages, or is not specific to AD, the theory would be called into question.</li>
                <li>If synaptic density loss is not observed in early AD or does not correlate with cognitive decline, the theory would be weakened.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Cases of AD with minimal network disconnection but severe atrophy or Aβ/tau pathology are not fully explained. <a href="../results/extraction-result-3938.html#e3938.10" class="evidence-link">[e3938.10]</a> <a href="../results/extraction-result-3938.html#e3938.6" class="evidence-link">[e3938.6]</a> <a href="../results/extraction-result-3938.html#e3938.5" class="evidence-link">[e3938.5]</a> <a href="../results/extraction-result-3938.html#e3938.9" class="evidence-link">[e3938.9]</a> <a href="../results/extraction-result-3938.html#e3938.0" class="evidence-link">[e3938.0]</a> <a href="../results/extraction-result-3938.html#e3938.2" class="evidence-link">[e3938.2]</a> </li>
    <li>The role of non-synaptic mechanisms (e.g., vascular, glial, or purely metabolic) in cognitive decline is not directly addressed. <a href="../results/extraction-result-3916.html#e3916.2" class="evidence-link">[e3916.2]</a> <a href="../results/extraction-result-3914.html#e3914.2" class="evidence-link">[e3914.2]</a> <a href="../results/extraction-result-3933.html#e3933.2" class="evidence-link">[e3933.2]</a> <a href="../results/extraction-result-3933.html#e3933.3" class="evidence-link">[e3933.3]</a> <a href="../results/extraction-result-3933.html#e3933.10" class="evidence-link">[e3933.10]</a> <a href="../results/extraction-result-3933.html#e3933.11" class="evidence-link">[e3933.11]</a> <a href="../results/extraction-result-3913.html#e3913.10" class="evidence-link">[e3913.10]</a> <a href="../results/extraction-result-3913.html#e3913.11" class="evidence-link">[e3913.11]</a> <a href="../results/extraction-result-3916.html#e3916.8" class="evidence-link">[e3916.8]</a> <a href="../results/extraction-result-3916.html#e3916.9" class="evidence-link">[e3916.9]</a> <a href="../results/extraction-result-3916.html#e3916.6" class="evidence-link">[e3916.6]</a> <a href="../results/extraction-result-3916.html#e3916.5" class="evidence-link">[e3916.5]</a> <a href="../results/extraction-result-3916.html#e3916.4" class="evidence-link">[e3916.4]</a> <a href="../results/extraction-result-3916.html#e3916.3" class="evidence-link">[e3916.3]</a> <a href="../results/extraction-result-3916.html#e3916.0" class="evidence-link">[e3916.0]</a> <a href="../results/extraction-result-3915.html#e3915.2" class="evidence-link">[e3915.2]</a> </li>
</ol>            <h3>Existing Theory Comparison</h3>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
            <p><strong>Explanation:</strong> No explanation provided.</p>
            <p><strong>References:</strong> <ul>
    <li>Seeley et al. (2009) Neurodegenerative diseases target large-scale human brain networks [network degeneration hypothesis]</li>
    <li>Buckner et al. (2005) Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory [DMN and amyloid]</li>
    <li>Palop & Mucke (2010) Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks [network/synaptic focus]</li>
    <li>This theory is novel in emphasizing the primacy of network/synaptic failure as the earliest and most functionally relevant event, and in proposing that detection should prioritize these biomarkers over traditional Aβ/tau/atrophy markers.</li>
</ul>
        </div>

        <div class="section">
            <h2>Theory Components (Debug)</h2>
            <pre><code>{
    "theory_name": "Network Disconnection and Synaptic Failure Theory of Alzheimer's Disease Detection",
    "theory_description": "This theory posits that the earliest and most functionally relevant events in Alzheimer's disease (AD) are disruptions of large-scale brain network connectivity and synaptic integrity, which can be detected by advanced neuroimaging and fluid biomarkers before substantial structural atrophy or overt clinical symptoms. The theory asserts that Aβ and tau pathologies, as well as metabolic, inflammatory, and vascular changes, converge on the synapse and network level, leading to impaired functional connectivity (especially in the default mode and memory networks) and synaptic loss, which are the proximate causes of cognitive decline. Therefore, the most sensitive and specific detection of AD, especially in preclinical and prodromal stages, is achieved by combining functional connectivity (fMRI, EEG/MEG), synaptic density (SV2A PET, neurogranin), and network-level biomarkers, rather than relying solely on Aβ/tau or structural atrophy.",
    "theory_statements": [
        {
            "law": {
                "law_name": "Early Network Disconnection Law",
                "if": [
                    {
                        "subject": "individual",
                        "relation": "is_in",
                        "object": "preclinical or prodromal AD stage"
                    }
                ],
                "then": [
                    {
                        "subject": "functional connectivity",
                        "relation": "is_reduced",
                        "object": "in default mode and memory networks (DMN, hippocampal circuits)"
                    },
                    {
                        "subject": "synaptic density",
                        "relation": "is_reduced",
                        "object": "regionally (e.g., SV2A PET, neurogranin)"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Resting-state fMRI, functional connectivity, and SV2A PET studies show early network and synaptic changes in AD and MCI, often before atrophy.",
                        "uuids": [
                            "e3910.1",
                            "e3923.8",
                            "e3936.3",
                            "e4031.5",
                            "e3902.0",
                            "e3940.13",
                            "e3936.8",
                            "e3910.7",
                            "e4025.0"
                        ]
                    },
                    {
                        "text": "Functional connectivity impairment (disconnection hypothesis) is observed in early AD and MCI, with high classification accuracy using rs-fMRI network features.",
                        "uuids": [
                            "e3902.0",
                            "e3910.1",
                            "e3923.8",
                            "e4025.0"
                        ]
                    },
                    {
                        "text": "Synaptic loss is observed early in AD and is the strongest pathological correlate of cognitive decline.",
                        "uuids": [
                            "e4031.5",
                            "e3936.3"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative"
            }
        },
        {
            "law": {
                "law_name": "Synaptic Failure as Final Common Pathway Law",
                "if": [
                    {
                        "subject": "Aβ and tau pathology",
                        "relation": "is_present",
                        "object": "in brain"
                    }
                ],
                "then": [
                    {
                        "subject": "synaptic function",
                        "relation": "is_disrupted",
                        "object": "leading to network disconnection and cognitive decline"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Synaptic loss is the strongest pathological correlate of cognitive decline; Aβ and tau are shown to disrupt synaptic function and connectivity.",
                        "uuids": [
                            "e4031.5",
                            "e3933.4",
                            "e3933.1",
                            "e3910.1",
                            "e3933.2",
                            "e3933.3",
                            "e3933.10",
                            "e3933.8"
                        ]
                    },
                    {
                        "text": "Aβ oligomers and tau pathology disrupt synaptic plasticity and network connectivity, leading to cognitive impairment.",
                        "uuids": [
                            "e3933.4",
                            "e3933.1",
                            "e3933.2"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative"
            }
        },
        {
            "law": {
                "law_name": "Functional Biomarker Superiority Law",
                "if": [
                    {
                        "subject": "detection_method",
                        "relation": "includes",
                        "object": "functional connectivity or synaptic density measures"
                    }
                ],
                "then": [
                    {
                        "subject": "early detection accuracy",
                        "relation": "is_greater_than",
                        "object": "detection using structural atrophy or Aβ/tau alone"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Functional imaging and synaptic markers (fMRI, SV2A PET, neurogranin) are sensitive to early changes and can predict conversion from MCI to AD.",
                        "uuids": [
                            "e3910.1",
                            "e3936.3",
                            "e4031.5",
                            "e3923.8",
                            "e3902.0",
                            "e4025.0",
                            "e3936.8"
                        ]
                    },
                    {
                        "text": "Deep learning and graph-based models using functional connectivity outperform or complement structural MRI in early-stage classification.",
                        "uuids": [
                            "e3910.7",
                            "e4025.0",
                            "e3910.8"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative"
            }
        },
        {
            "law": {
                "law_name": "Network Disconnection Precedes Structural Atrophy Law",
                "if": [
                    {
                        "subject": "individual",
                        "relation": "is_in",
                        "object": "preclinical or prodromal AD stage"
                    }
                ],
                "then": [
                    {
                        "subject": "network connectivity",
                        "relation": "is_reduced",
                        "object": "before measurable hippocampal or cortical atrophy"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "fMRI studies show DMN and hippocampal connectivity loss precedes gray matter loss; functional changes are detectable before atrophy.",
                        "uuids": [
                            "e3940.13",
                            "e3910.1",
                            "e3923.8",
                            "e3936.8",
                            "e4025.0"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative"
            }
        }
    ],
    "new_predictions_likely": [
        "Longitudinal studies will show that reductions in DMN connectivity and synaptic density (by fMRI/SV2A PET/neurogranin) precede measurable hippocampal atrophy or clinical symptoms in at-risk individuals.",
        "Combining functional connectivity and synaptic biomarkers with Aβ/tau markers will improve prediction of cognitive decline and conversion from MCI to AD.",
        "Individuals with preserved network connectivity and synaptic density, despite Aβ/tau positivity, will have slower or absent cognitive decline.",
        "Early interventions that restore or preserve network connectivity will delay onset of clinical symptoms even in biomarker-positive individuals."
    ],
    "new_predictions_unknown": [
        "Interventions that restore or preserve network connectivity and synaptic function (e.g., synaptoprotective drugs, neuromodulation) will prevent or delay cognitive decline even in the presence of Aβ/tau pathology.",
        "Distinct patterns of network disconnection (e.g., DMN vs. attention networks) will predict different clinical phenotypes or rates of progression in AD.",
        "Non-invasive EEG/MEG network biomarkers will be as sensitive as fMRI or PET for early AD detection.",
        "Network-level biomarkers will allow subtyping of AD with different progression rates or responses to therapy."
    ],
    "negative_experiments": [
        "If individuals with early Aβ/tau pathology but preserved network connectivity and synaptic density develop cognitive decline at the same rate as those with network disruption, the theory would be challenged.",
        "If functional connectivity and synaptic biomarkers do not improve early detection or prediction of progression compared to structural or Aβ/tau markers alone, the theory's central claim would be undermined.",
        "If network disconnection is not observed in preclinical or prodromal stages, or is not specific to AD, the theory would be called into question.",
        "If synaptic density loss is not observed in early AD or does not correlate with cognitive decline, the theory would be weakened."
    ],
    "unaccounted_for": [
        {
            "text": "Cases of AD with minimal network disconnection but severe atrophy or Aβ/tau pathology are not fully explained.",
            "uuids": [
                "e3938.10",
                "e3938.6",
                "e3938.5",
                "e3938.9",
                "e3938.0",
                "e3938.2"
            ]
        },
        {
            "text": "The role of non-synaptic mechanisms (e.g., vascular, glial, or purely metabolic) in cognitive decline is not directly addressed.",
            "uuids": [
                "e3916.2",
                "e3914.2",
                "e3933.2",
                "e3933.3",
                "e3933.10",
                "e3933.11",
                "e3913.10",
                "e3913.11",
                "e3916.8",
                "e3916.9",
                "e3916.6",
                "e3916.5",
                "e3916.4",
                "e3916.3",
                "e3916.0",
                "e3915.2"
            ]
        }
    ],
    "conflicting_evidence": [
        {
            "text": "Some studies report that structural atrophy or Aβ/tau markers can predict progression as well or better than functional connectivity in certain cohorts.",
            "uuids": [
                "e3938.10",
                "e3938.6",
                "e3938.5",
                "e3938.9",
                "e3938.0",
                "e3938.2",
                "e3932.4",
                "e3932.5",
                "e3932.6",
                "e3932.7",
                "e3932.8"
            ]
        },
        {
            "text": "Structural MRI and CSF/PET Aβ/tau markers are widely used and validated for early detection and prediction, sometimes outperforming functional measures.",
            "uuids": [
                "e3932.4",
                "e3932.5",
                "e3932.6",
                "e3932.7",
                "e3932.8",
                "e3938.10",
                "e3938.6"
            ]
        }
    ],
    "special_cases": [
        "Individuals with comorbid vascular or psychiatric conditions may show network disconnection unrelated to AD pathology.",
        "Familial AD may show different temporal relationships between Aβ/tau and network changes.",
        "Network disconnection may be present in other neurodegenerative or psychiatric disorders, reducing specificity."
    ],
    "existing_theory": {
        "likely_classification": "closely-related-to-existing",
        "references": [
            "Seeley et al. (2009) Neurodegenerative diseases target large-scale human brain networks [network degeneration hypothesis]",
            "Buckner et al. (2005) Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory [DMN and amyloid]",
            "Palop & Mucke (2010) Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks [network/synaptic focus]",
            "This theory is novel in emphasizing the primacy of network/synaptic failure as the earliest and most functionally relevant event, and in proposing that detection should prioritize these biomarkers over traditional Aβ/tau/atrophy markers."
        ]
    },
    "theory_type_general_specific": "general",
    "reflected_from_theory_index": 1,
    "version": "built-theory-from-results-single-theory-reflection2-nov13-2025",
    "type": "general"
}</code></pre>
        </div>
    </div>
</body>
</html>